Based in San Francisco, California, North South Ventures has a presence in academic med superclusters such as Stanford/UCSF and University of Toronto, giving them access to proprietary deal flow from top US and Canadian academic centres. With a track record of investing in over 350 medical portfolio companies and achieving 40+ FDA approvals in the biotech, med device, and digital health/AI spaces, they have accumulated $4B+ in funding and have had three multi-billion dollar IPOs since 2012.